You are now leaving XTANDI.com
The website you are about to visit is not owned or controlled by Astellas. Astellas are not responsible for the information or services on this site.
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Our consistent top score demonstrates our continuing effort to create an inclusive culture for people with disabilities. For the fourth year in a row, Astellas has been included in the Disability...
As a global pharmaceutical company, Astellas takes the fight against cancer personally and is deeply committed to our employees and customers who are a part of the oncology community. Fifty...
Astellas Executive Vice President and Head of Medical Affairs Shontelle Dodson and Vice President, Head of Biopharma Development Marci English were recently featured in an Axios Smart Brevity...
Astellas provides biopharma industry experience for PharmD students When Astellas learned that the Chicago State University College of Pharmacy did not offer a biopharma industry rotation as part...
Astellas congratulates Judy Kannenberg, Vice President, Regulatory Affairs Therapeutic Area Head of Medical Specialties, for being named a 2023 Healthcare Businesswomen’s Association (HBA)...
Astellas was recently ranked in Seramount’s 2022 list of 100 Best Companies and Best Companies for Dads highlighting our commitment to creating a workplace where working parents are valued and...
Astellas ranked again in Seramount’s 2022 “100 Best Companies” list and Best Companies for Dads
C3 Prize Winner Shares How Her Father’s Experience with Cancer Inspired Her to Create New Patient App Astellas Pharma senior vice president and global head of Patient Centricity Dr. Anthony...
Great Place to Work® and Fortune magazine have honored Astellas as one of the 2022 Best Workplaces in BioPharma™. This is Astellas’ first time being named to this prestigious list, coming in...
Our consistent score of 100 recognizes our continuing effort to create an inclusive culture for people with disabilities. For the third year in a row, Astellas has been included in the Disability...
![]() |
Get only the email alerts you want.
For media inquiries and reporter requests, please click here to fill out a request form.
Our communications team will respond to verified media requests within 24-48 hours as appropriate.
If you are not a reporter and need assistance, please visit our contact us page that includes information for patients, healthcare providers and researchers.
This website is intended for U.S. residents only. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including those under development. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.
The site uses cookies to provide you with a more responsive and personalized service and to analyze site traffic. By using this site, you accept our use of cookies as described in our privacy policy. Please read our privacy policy for more information on the cookies we use, the processing of your personal data and how to delete or block the use of cookies.